PainReform ( (PRFX) ) has shared an announcement.
On March 5, 2025, PainReform Ltd. completed its acquisition of DeepSolar, an AI-driven solar analytics platform, from BladeRanger Ltd. This strategic move marks PainReform’s entry into the rapidly expanding clean energy sector, leveraging DeepSolar’s AI solutions to optimize solar energy management. The acquisition is expected to generate long-term value through recurring revenue streams and reduced operational costs for customers, positioning PainReform as a potential leader in solar asset optimization. The transaction also aligns with PainReform’s broader strategy to invest in high-margin, technology-driven sectors while continuing its pharmaceutical innovations.
More about PainReform
PainReform Ltd. is a clinical-stage specialty pharmaceutical company focused on reformulating established therapeutics. The company aims to provide extended post-surgical pain relief through its proprietary extended-release drug-delivery system, reducing the need for repeated doses and minimizing opioid use.
YTD Price Performance: -8.33%
Average Trading Volume: 2,939,880
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.6M
For a thorough assessment of PRFX stock, go to TipRanks’ Stock Analysis page.